Paul Chaplin
Chief Executive Officer en BAVARIAN NORDIC A/S .
Cargos activos de Paul Chaplin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BAVARIAN NORDIC A/S | Chief Executive Officer | 28/05/2014 | - |
| President | 28/05/2014 | - | |
| Chief Tech/Sci/R&D Officer | 01/01/2004 | 10/02/2012 | |
| Corporate Officer/Principal | 10/02/2012 | 28/05/2014 | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Corporate Officer/Principal | 03/03/2011 | - |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | President | - | - |
Historial de carrera de Paul Chaplin
Formación de Paul Chaplin.
| University of Bristol | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 2 |
| Dinamarca | 2 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| President | 2 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BAVARIAN NORDIC A/S | Health Technology |
| Empresas privadas | 2 |
|---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Chaplin
- Experiencia
